首页 | 本学科首页   官方微博 | 高级检索  
检索        

奈替米星和司帕沙星联合治疗耐多药肺结核近期疗效分析
引用本文:陈尊杰,谢汉彬,黄俊明,洪梅,黄钥藩.奈替米星和司帕沙星联合治疗耐多药肺结核近期疗效分析[J].临床肺科杂志,2011,16(4):548-549.
作者姓名:陈尊杰  谢汉彬  黄俊明  洪梅  黄钥藩
作者单位:汕头,汕头市第三人民医院,广东,515073
摘    要:目的评价含奈替米星和司帕沙星联合对耐多药肺结核(MDR-PTB)的疗效。方法 348例MDR-PTB患者,随机分为两组,以氧氟沙星和丁胺卡那霉素作为对照组。治疗组174例采用3NSDTZ(E)/9SDTZ(E)方案治疗,对照组174例采用3AODTZ(E)/9ODTZ(E)方案治疗。结果第3个月末,治疗组痰菌转阴率为72%,明显优于对照组(48%),两组对照有统计学上的显著性意义(P〈0.05)。疗程结束时,治疗组痰菌转阴率为89%,明显优于对照组(68%),两组对照有统计学的显著性意义(P〈0.05)。结论以奈替米星和司帕沙星联合治疗MDR-PTB疗效肯定,痰菌转阴速度快,值得继续临床探索。

关 键 词:结核  肺/药物疗法  耐多药  奈替米星  司帕沙星

The therapeutic effect of netilmicin and sparfloxacin on multidrug resistant pulmonary tuberculosis
CHEN Zun-jie,XIN Han-bin,HUANG Jun-ming,HONG Mei,HUANG Yue-fan.The therapeutic effect of netilmicin and sparfloxacin on multidrug resistant pulmonary tuberculosis[J].Journal of Clinical Pulmonary Medicine,2011,16(4):548-549.
Authors:CHEN Zun-jie  XIN Han-bin  HUANG Jun-ming  HONG Mei  HUANG Yue-fan
Institution:The third people′s hospital of Shantou city515073,China
Abstract:Objective To evaluate the therapeutic effect of netilmicin and sparfloxacin on multldrug resistant pulmonary tuberculosis(MDR-PTB).Methods348 cases of MDR-PTB were allocated at random pair to two groups,using domestic ofloxacin and amikacin as comparison.174 cases were treated with the regimen of 3NSDTZ(E)/9SDTZ(E).174 cases were treated with the regimen of 3AODTZ(E)/9ODTZ(E).ResultsAt the end of third mouth,the sputum negative conversion rates of treatment group were 72%,which evidently gained an advantage...
Keywords:Tuberculosis  pulmonary/drug therapy  Multidrop  Netilmicin Sparfloxacin  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号